This Weekly’s Hot Topics

  • 2017 Administrator & Oncology Billing Programs, November 8th& 9th (MOASC  News)
  • The growing IV fluid shortage (National News)
  • Reimbursement cut for separately paid drugs under the 340B Drug Pricing Program (CMS News)

 

The California Health Information Partnership & Services Organization (CalHIPSO) can help practices with 15 or fewer physicians with free assistance to prepare and participate in the Medicare QPP. For more information click here and go to California News.

MEMBER ONCOLOGIST CLOSING PRACTICE, DRUG STOCK AVAILABLE. A MOASC member is closing their practice and has leftover stock available. If you are interested in purchasing some of leftover stock of chemo meds, please contact moasc@moasc.org for the list of drugs and information.

Anthem Blue Cross will conduct post-payment coding reviews of professional claims billed with modifiers 25, 62, 80, 81, AS, and 91 beginning in 4Q2017. Additionally, Anthem will conduct post-payment coding reviews of E&M services billed during a global surgery period. For more information click here and go to National News.

CMS, in its final rule on the 2018 HOPSS, has finalized a proposal to cut reimbursement for separately paid drugs under the 340B Drug Pricing Program from ASP plus 6% to ASP minus 22.5%. Rural Sole Community Hospitals, PPS-exempt Cancer Hospitals, and Children’s hospitals will be exempt from this policy in 2018. For more information click here and go to CMS News.

 

To view the complete California Oncology Weekly Newsletter, click on the date below.

November 7, 2017